Effect of Genetic Alterations Affecting the Genes Encoding the Major Enzymes of the Kynurenine Pathway on Suicidal Behavior (SuiKYN)
Étude Des Altérations Génétiques (polymorphismes) Des Gènes-clés De La Voie Kynurénine Sur Le Comportement Suicidaire
Sponsor: Centre Hospitalier Universitaire de Nīmes
Listed as NCT04565834, this observational or N/A phase trial focuses on Polymorphism and Suicidal Behavior and remains completed. Sponsored by Centre Hospitalier Universitaire de Nīmes, it has been updated 10 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Mar 2025 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Mar 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
May 2022 — Feb 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jan 2022 — May 2022 [monthly]
Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nīmes
- Universidad Autonoma de Madrid
For direct contact, visit the study record on ClinicalTrials.gov .